[Metabolic interaction between cimetidine, ranitidine and amitriptyline/chlordiazepoxide]

Area of Science:

• Pharmacology
• Drug Interactions
• Clinical Pharmacology

Background:

• Amitriptyline and chlordiazepoxide are commonly prescribed medications.
• H2-receptor antagonists like cimetidine and ranitidine are used to reduce stomach acid.
• Potential interactions between these drug classes require investigation.

Purpose of the Study:

• To evaluate the effects of cimetidine and ranitidine on the plasma levels of amitriptyline and chlordiazepoxide.
• To determine if coadministration of these H2-blockers with amitriptyline/chlordiazepoxide leads to significant pharmacokinetic changes.

Main Methods:

• Biphasic study involving 12 healthy young male volunteers.
• Subjects received amitriptyline/chlordiazepoxide, followed by either cimetidine or ranitidine.
• Plasma drug levels and metabolites were analyzed using High-Performance Liquid Chromatography (HPLC).
• Key pharmacokinetic parameters included area under the plasma level-time curve (AUC), total clearance, and terminal half-life.

Main Results:

• Cimetidine significantly increased plasma levels of both amitriptyline and chlordiazepoxide (p<0.05).
• Ranitidine did not produce significant changes in the plasma levels of amitriptyline or chlordiazepoxide.
• No significant alterations in metabolite levels were mentioned, focusing on parent drug concentrations.

Conclusions:

• Cimetidine interacts with amitriptyline and chlordiazepoxide, leading to elevated plasma concentrations.
• Ranitidine does not appear to interact with amitriptyline and chlordiazepoxide under the studied conditions.
• Ranitidine is the preferred H2-blocker when coadministration with amitriptyline and/or chlordiazepoxide is necessary.